U.S. health regulators are defending their handling of Moderna’s mRNA flu vaccine application after initially declining to review it, while signaling the decision may not be final.[#item_full_content]
Wall Street Falls on Worries About War, Interest Rates
Wall Street indexes fell in Tuesday’s volatile session as investors swayed between fears of rising oil prices and hopes for a resolution to the U.S.-Israeli